RSS Feed

Latest news

Arthritis biologic approved for NHS prescribing

Arthritis biologic approved for NHS prescribing

Sarilumab (Kevzara) is to be funded on the NHS, following...

Fingerprick-free glucose monitoring system available on the NHS

Fingerprick-free glucose monitoring system available on the NHS

A glucose monitoring system that does not require regular...

Infographic: Statins not prescribed in two thirds of high-risk patients

Infographic: Statins not prescribed in two thirds of high-risk patients

Prescribing of statins in high-risk patients has decreased...

Risk of serious skin reactions with anaemia drugs

Risk of serious skin reactions with anaemia drugs

Severe cutaneous adverse reactions can occur in patients...

Clozapine prescribers reminded of intestinal obstruction risk

Clozapine prescribers reminded of intestinal obstruction risk

Clozapine can impair intestinal peristalsis, leading...


New and deleted products

Promo Image

New Products

Products added to MIMS

Promo Image

Deleted Products

Products removed from MIMS


Most popular

Hormone Replacement Therapy (HRT)

Hormone doses and costs of HRT preparations.

Antidepressants, a Guide to Switching and Withdrawing

Instructions for changing or stopping antidepressants.

Blood Glucose Testing Strips and Meters

Compatible test strips for blood glucose meters.

Contraceptives

Hormone doses and costs of hormonal contraceptives.

H.pylori: Eradication Regimens (NICE)

Summary of NICE guidance on Helicobacter treatment.


Featured MIMS resources

Promo Image

Routine childhood immunisation schedule

Quick-reference summary of the UK childhood vaccination programme.

Promo Image

Menopause: diagnosis and management

At-a-glance summary of the first NICE guideline on menopause.


Manufacturers

Manufacturers

Contact details and drug listings for manufacturers in MIMS


New products coming soon to MIMS

Check back soon to find MIMS listings for the following new drugs:

Brinavess (vernakalant)

Fertavid (follitropin beta)

Kyleena (levonorgestrel)

Panzyga (human normal immunoglobulin)

Suliqua (insulin glargine/lixisenatide)

Vemlidy (tenofovir alafenamide fumarate)


Partner CPD from MIMS Learning

knowledge 0.5 Credits

Initiated, funded and reviewed by Reckitt Benckiser. Date of Preparation: February 2017; UK/E45-NHS/0916/0013j

WEBCAST 1 Credit

Lessons from the Ealing GP Federation Funding for this educational programme has been provided by Bayer, Boehringer Ingelheim and Daiichi Sankyo. None of the companies have had any influence or input into its content.

Webcast 0.5 Credits

This learning module has been initiated, funded and reviewed by Edwards Lifesciences.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

This site is intended for healthcare professionals.